These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
243 related articles for article (PubMed ID: 24924617)
1. Nano carriers that enable co-delivery of chemotherapy and RNAi agents for treatment of drug-resistant cancers. Tsouris V; Joo MK; Kim SH; Kwon IC; Won YY Biotechnol Adv; 2014; 32(5):1037-50. PubMed ID: 24924617 [TBL] [Abstract][Full Text] [Related]
2. An overview of the effective combination therapies for the treatment of breast cancer. Núñez C; Capelo JL; Igrejas G; Alfonso A; Botana LM; Lodeiro C Biomaterials; 2016 Aug; 97():34-50. PubMed ID: 27162073 [TBL] [Abstract][Full Text] [Related]
3. Gene/paclitaxel co-delivering nanocarriers prepared by framework-induced self-assembly for the inhibition of highly drug-resistant tumors. Wang C; Guan W; Peng J; Chen Y; Xu G; Dou H Acta Biomater; 2020 Feb; 103():247-258. PubMed ID: 31846802 [TBL] [Abstract][Full Text] [Related]
4. Role of integrated cancer nanomedicine in overcoming drug resistance. Iyer AK; Singh A; Ganta S; Amiji MM Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506 [TBL] [Abstract][Full Text] [Related]
5. Polymers in the Co-delivery of siRNA and Anticancer Drugs for the Treatment of Drug-resistant Cancers. Sun H; Yarovoy I; Capeling M; Cheng C Top Curr Chem (Cham); 2017 Apr; 375(2):24. PubMed ID: 28176270 [TBL] [Abstract][Full Text] [Related]
6. The synergistic effect of hierarchical assemblies of siRNA and chemotherapeutic drugs co-delivered into hepatic cancer cells. Cao N; Cheng D; Zou S; Ai H; Gao J; Shuai X Biomaterials; 2011 Mar; 32(8):2222-32. PubMed ID: 21186059 [TBL] [Abstract][Full Text] [Related]
7. Overcoming multidrug resistance by RNA interference. Stege A; Krühn A; Lage H Methods Mol Biol; 2010; 596():447-65. PubMed ID: 19949936 [TBL] [Abstract][Full Text] [Related]
8. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411 [TBL] [Abstract][Full Text] [Related]
9. Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances. Gandhi NS; Tekade RK; Chougule MB J Control Release; 2014 Nov; 194():238-56. PubMed ID: 25204288 [TBL] [Abstract][Full Text] [Related]
10. Overcoming the classical multidrug resistance phenotype by adenoviral delivery of anti-MDR1 short hairpin RNAs and ribozymes. Kaszubiak A; Holm PS; Lage H Int J Oncol; 2007 Aug; 31(2):419-30. PubMed ID: 17611700 [TBL] [Abstract][Full Text] [Related]
11. Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat. Cheng D; Cao N; Chen J; Yu X; Shuai X Biomaterials; 2012 Feb; 33(4):1170-9. PubMed ID: 22061491 [TBL] [Abstract][Full Text] [Related]
12. Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy. Zheng C; Zheng M; Gong P; Deng J; Yi H; Zhang P; Zhang Y; Liu P; Ma Y; Cai L Biomaterials; 2013 Apr; 34(13):3431-8. PubMed ID: 23375952 [TBL] [Abstract][Full Text] [Related]
13. Molecular mechanisms of multidrug resistance in cancer chemotherapy. Nooter K; Stoter G Pathol Res Pract; 1996 Jul; 192(7):768-80. PubMed ID: 8880878 [TBL] [Abstract][Full Text] [Related]
14. Tumor-specific delivery of siRNA using supramolecular assembly of hyaluronic acid nanoparticles and 2b RNA-binding protein/siRNA complexes. Choi KM; Jang M; Kim JH; Ahn HJ Biomaterials; 2014 Aug; 35(25):7121-32. PubMed ID: 24854094 [TBL] [Abstract][Full Text] [Related]
15. Integrated hollow mesoporous silica nanoparticles for target drug/siRNA co-delivery. Ma X; Zhao Y; Ng KW; Zhao Y Chemistry; 2013 Nov; 19(46):15593-603. PubMed ID: 24123533 [TBL] [Abstract][Full Text] [Related]
16. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel. Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347 [TBL] [Abstract][Full Text] [Related]
17. Low-density lipoprotein-coupled N-succinyl chitosan nanoparticles co-delivering siRNA and doxorubicin for hepatocyte-targeted therapy. Zhu QL; Zhou Y; Guan M; Zhou XF; Yang SD; Liu Y; Chen WL; Zhang CG; Yuan ZQ; Liu C; Zhu AJ; Zhang XN Biomaterials; 2014 Jul; 35(22):5965-76. PubMed ID: 24768047 [TBL] [Abstract][Full Text] [Related]
18. Polymeric delivery of siRNA for dual silencing of Mcl-1 and P-glycoprotein and apoptosis induction in drug-resistant breast cancer cells. Aliabadi HM; Mahdipoor P; Uludağ H Cancer Gene Ther; 2013 Mar; 20(3):169-77. PubMed ID: 23449477 [TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-mediated drug resistance. Zeng X; Morgenstern R; Nyström AM Biomaterials; 2014 Jan; 35(4):1227-39. PubMed ID: 24210875 [TBL] [Abstract][Full Text] [Related]
20. SiRNA-phospholipid conjugates for gene and drug delivery in cancer treatment. Liu H; Li Y; Mozhi A; Zhang L; Liu Y; Xu X; Xing J; Liang X; Ma G; Yang J; Zhang X Biomaterials; 2014 Aug; 35(24):6519-33. PubMed ID: 24797882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]